Welcome!

News Feed Item

Innovative Luneray catheters and organ-preserving approach result in radically less invasive bladder cancer treatment

Urologist and radiation oncologist collaborate in laparoscopic implantation of new brachytherapy catheters for bladder cancer

ARNHEM, Netherlands, April 7, 2014 /PRNewswire/ -- Physicians at Arnhem Radiotherapy Institute (ARTI) and Rijnstate Hospital have dramatically transformed brachytherapy to treat bladder cancer. By employing new sophisticated Luneray™ brachytherapy catheters by Nucletron, an Elekta company, and robot-assisted laparoscopy, clinicians can treat bladder cancer patients far less invasively than previously possible, enabling bladder preservation in an increased number of patients.

On January 20, ARTI radiation oncologist Dr. Elzbieta van der Steen-Banasik and Rijnstate urologist Dr. Geert Smits used the technique they developed to treat an 80-year-old male patient with bladder cancer. He was the first in which the physicians debuted the recently introduced Luneray brachytherapy catheters. The ARTI-Rijnstate clinicians have been working in close collaboration with Nucletron perfecting the needle-catheter solution.

"The patient had a small T3 tumor that we treated initially with a four-week course of external beam radiation therapy (EBRT)," Dr. Smits says. "We then removed a bladder diverticule – where the tumor was located – with a partial cystectomy.  During the same procedure we implanted two Luneray catheters using our robot-assisted laparoscopic approach and delivered the first of 10 brachytherapy fractions of 2.5 Gy each. The remaining nine fractions were delivered over the next three days. After the tenth fraction, the catheters were removed and the patient went home. There were no complications and he is doing well."

ARTI-Rijnstate's laparoscopic method with Luneray is a vast improvement over the traditional open surgical procedure for implanting brachytherapy catheters. After an initial EBRT course, the traditional method involved a large incision to expose the bladder, then opening the bladder for implantation of catheters. This complex procedure often incurs lengthy hospitalization and the possibility of wound and bladder infections.

"The laparoscopic technique involves just four 8-10 mm incisions in the abdominal wall for the insertion of instruments and, in most cases, minimal manipulation of the bladder wall, resulting in significant reduction in tissue trauma," Dr. van der Steen-Banasik explains. "Also hospitalization is dramatically shorter – an average of just six days, versus 17 days on average for the open procedure." 

Innovative Luneray needle-catheter
The Luneray catheters are a critical component in the success of ARTI-Rijnstate's minimally invasive bladder brachytherapy program. Both Dr. Smits and Dr. van der Steen-Banasik worked together with Nucletron to create an entirely new class of pre-assembled brachytherapy needle/catheter applicators for laparoscopic use. The needles have a slight curve to enable optimal access to the targeted part of the bladder. The catheters are made of the same innovative material as the also recently introduced LumenCare™ Azure applicator for lung brachytherapy. This unique material makes the applicators strong, yet flexible and highly kink-resistant.

"The availability of Luneray catheters really creates new possibilities to treat selected bladder cancers in a minimally invasive way using brachytherapy," Dr. van der Steen-Banasik observes. "We hope that more patients will benefit from this bladder-sparing treatment in the future."

*Luneray is pending US FDA 510(k) clearance and not available for sale or distribution in all markets.

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: [email protected]
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, e-mail: [email protected]
Time zone: EST: Eastern Standard Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.

SOURCE Elekta

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists will examine how DevOps helps to meet th...
SYS-CON Events announced today that Hitachi, the leading provider the Internet of Things and Digital Transformation, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Hitachi Data Systems, a wholly owned subsidiary of Hitachi, Ltd., offers an integrated portfolio of services and solutions that enable digital transformation through enhanced data management, governance, mobility and analytics. We help globa...
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
SYS-CON Events announced today that T-Mobile will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. As America's Un-carrier, T-Mobile US, Inc., is redefining the way consumers and businesses buy wireless services through leading product and service innovation. The Company's advanced nationwide 4G LTE network delivers outstanding wireless experiences to 67.4 million customers who are unwilling to compromise on ...
@DevOpsSummit has been named the ‘Top DevOps Influencer' by iTrend. iTred processes millions of conversations, tweets, interactions, news articles, press releases, blog posts - and extract meaning form them and analyzes mobile and desktop software platforms used to communicate, various metadata (such as geo location), and automation tools. In overall placement, @DevOpsSummit ranked as the number one ‘DevOps Influencer' followed by @CloudExpo at third, and @MicroservicesE at 24th.
The goal of Continuous Testing is to shift testing left to find defects earlier and release software faster. This can be achieved by integrating a set of open source functional and performance testing tools in the early stages of your software delivery lifecycle. There is one process that binds all application delivery stages together into one well-orchestrated machine: Continuous Testing. Continuous Testing is the conveyor belt between the Software Factory and production stages. Artifacts are ...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
SYS-CON Events announced today that Juniper Networks (NYSE: JNPR), an industry leader in automated, scalable and secure networks, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. The company co-innovates with customers and partners to deliver automated, scalable and secure network...
The age of Digital Disruption is evolving into the next era – Digital Cohesion, an age in which applications securely self-assemble and deliver predictive services that continuously adapt to user behavior. Information from devices, sensors and applications around us will drive services seamlessly across mobile and fixed devices/infrastructure. This evolution is happening now in software defined services and secure networking. Four key drivers – Performance, Economics, Interoperability and Trust ...
Quickly find the root cause of complex database problems slowing down your applications. Up to 88% of all application performance issues are related to the database. DPA’s unique response time analysis shows you exactly what needs fixing - in four clicks or less. Optimize performance anywhere. Database Performance Analyzer monitors on-premises, on VMware®, and in the Cloud, including Amazon® AWS and Azure™ virtual machines.
Back in February of 2017, Andrew Clay Schafer of Pivotal tweeted the following: “seriously tho, the whole software industry is stuck on deployment when we desperately need architecture and telemetry.” Intrigue in a 140 characters. For me, I hear Andrew saying, “we’re jumping to step 5 before we’ve successfully completed steps 1-4.”
DevOps is often described as a combination of technology and culture. Without both, DevOps isn't complete. However, applying the culture to outdated technology is a recipe for disaster; as response times grow and connections between teams are delayed by technology, the culture will die. A Nutanix Enterprise Cloud has many benefits that provide the needed base for a true DevOps paradigm.
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
SYS-CON Events announced today that SoftLayer, an IBM Company, has been named “Gold Sponsor” of SYS-CON's 18th Cloud Expo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. SoftLayer, an IBM Company, provides cloud infrastructure as a service from a growing number of data centers and network points of presence around the world. SoftLayer’s customers range from Web startups to global enterprises.
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...